{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-025334","form_type":"8-K","ticker":"OWLT","cik":"0001816708","company_name":"Owlet, Inc.","filed_at":"2023-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.394232+00:00","generated_at":"2026-06-13T05:04:34.489203+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Owlet appoints Melissa Gonzales to board; brings women's health and consumer healthcare expertise","bullets":["Melissa Gonzales appointed as Class I director effective July 18, 2023, term expiring at 2025 annual meeting.","Gonzales is President, Women's Health at Myriad Genetics (MYGN) and brings 20+ years healthcare experience.","She will receive annual cash retainer of $50k and initial RSU grant valued ~$150k prorated.","Owlet CEO cites Gonzales' expertise as key as company prepares to launch BabySat FDA-cleared pulse oximetry device.","Gonzales also serves as Board Chair of March of Dimes, Chicago."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-025334","json":"https://secwatch.observer/filing/0001628280-23-025334.json","markdown":"https://secwatch.observer/filing/0001628280-23-025334.md","text":"https://secwatch.observer/filing/0001628280-23-025334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/0001628280-23-025334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/owlt-20230718.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T05:04:34.489203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"853b7a45fa","claim":"Melissa Gonzales was appointed as Class I director at Owlet, Inc..","evidence_excerpt":"appointed Melissa Gonzales to serve as a Class I director of the Board, effective July 18, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/0001628280-23-025334-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}